HT
INO icon

HAP Trading’s Inovio Pharmaceuticals INO Stock Holding History

HAP Trading’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,517
Closed -$1K – 1435
2022
Q4 		$1K Buy
4,517
+50
+1% +$1.13K ﹤0.01% 1412
2022
Q3 		$6K Buy
4,467
+675
+18% +$17.3K ﹤0.01% 1415
2022
Q2 		$4K Buy
3,792
+584
+18% +$16.5K ﹤0.01% 1660
2022
Q1 		$7K Sell
3,208
-5,134
-62% -$231K ﹤0.01% 1870
2021
Q4 		$29K Buy
8,342
+1,634
+24% +$131K ﹤0.01% 1679
2021
Q3 		$16K Sell
6,708
-1,125
-14% -$113K ﹤0.01% 1867
2021
Q2 		$121K Buy
7,833
+575
+8% +$55.2K ﹤0.01% 1154
2021
Q1 		$104K Sell
7,258
-767
-10% -$101K 0.01% 945
2020
Q4 		$68K Sell
8,025
-4,658
-37% -$620K ﹤0.01% 1305
2020
Q3 		$141K Buy
12,683
+4,200
+50% +$876K 0.01% 728
2020
Q2 		$1.08M Buy
8,483
+2,683
+46% +$431K 0.06% 268
2020
Q1 		$98K Buy
+5,800
New +$358K 0.01% 668
2017
Q2 		– Sell
-1,258
Closed -$4K – 1054
2017
Q1 		$4K Buy
+1,258
New +$100K ﹤0.01% 973

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HAP Trading's INO Position: Q4 2021 in Review

HAP Trading sold out of Inovio Pharmaceuticals (INO) in Q4 2021, closing a stake of 2,915 shares — an estimated $234K sold.

HAP Trading first reported a position in INO in Q1 2021 and held it in 2 quarters. The position peaked at $250K in Q3 2021. 208 funds tracked by Wall St. Rank hold INO as of Q4 2021.

  • HAP Trading reported no remaining Inovio Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 2,915 Inovio Pharmaceuticals shares in Q4 2021, an estimated $234K.
  • HAP Trading first reported a position in Inovio Pharmaceuticals in Q1 2021 and held it in 2 quarters.
  • HAP Trading's Inovio Pharmaceuticals position peaked at $250K in Q3 2021.
  • 208 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.